Neurometabolic signatures of addiction vulnerability and heroin versus social seeking: a PET study in rats

This study investigated the neurobiological underpinnings of addiction vulnerability by comparing rats trained to self-administer heroin versus saline. The researchers utilized a novel behavioral model that forces a choice between heroin and social interaction, capturing individual differences in addiction severity. To understand the brain-wide metabolic correlates of this vulnerability, the team employed 2-deoxy-2-[¹⁸F]fluoro-D-glucose (FDG) PET imaging during prolonged abstinence. The study assessed metabolic activity both at rest (homecage) and during behavioral tasks involving heroin or social reward seeking, then correlated these patterns with an addiction severity score derived from heroin intake, binge-like patterns, and behavioral choice metrics.

Contrary to common theories suggesting that opioid addiction causes generalized deficits in natural reward processing, the researchers found that social-seeking behavior remained intact in heroin-trained rats. Metabolic activation during social seeking was comparable between heroin-trained and control rats, indicating that opioid exposure did not impair the neural processing of natural social rewards in this model. Instead, addiction severity was strongly associated with resting-state metabolic alterations in the ventral hippocampus and piriform cortex. During active heroin seeking, higher addiction severity correlated with reduced metabolic activity in the post-subiculum and cerebellum. These findings suggest that individual vulnerability to addiction is characterized more by baseline metabolic shifts than by transient changes during reward-seeking episodes.

These findings suggest that social reinforcement remains a viable, intact system for therapeutic intervention in opioid addiction. By identifying specific neurometabolic signatures associated with addiction severity—such as altered activity in the ventral hippocampus and piriform cortex—this research provides potential biomarkers for risk assessment and suggests that neuromodulation strategies could target these specific resting-state networks to treat addiction vulnerability. The study reinforces the importance of using behavioral models that include naturalistic choices to distinguish between global reward deficits and specific drug-biased reward valuations.